Carbapenem resistance in gram-negative bacteria has caused a global epidemic that
continues to grow. Although carbapenemase-producing Enterobacteriaceae have received …

Background Accurate estimates of the burden of antimicrobial resistance (AMR) are needed
to establish the magnitude of this global threat in terms of both health and cost, and to …

Background This study aimed to investigate the epidemiology, microbiology, and risk factors
associated with mortality and multi-drug resistance bacterial bloodstream infections (BSIs) …

The aim of this study was to identify risk factors for mortality in patients suffering from
hematological malignancies (HMs) with bloodstream infections (BSIs) caused by Klebsiella …

Carbapenem-resistant Enterobacteriaceae (CRE) are a major global public health concern
and pose a serious threat to immunocompromised hosts, particularly patients with …

Background: Carbapenem-resistant Gram-negative bacteria are recognized as a cause of
difficult-to-treat infections associated with high mortality. Objectives: To perform a systematic …

Background: Carbapenem resistant Klebsiella pneumoniae (CRKP), Pseudomonas
aeruginosa (CRPA), and Acinetobacter baumannii (CRAB) pose significant threats to public …

Carbapenemase-producing Klebsiella pneumoniae (CP-Kp) are currently among the most
important nosocomial pathogens in many geographic regions. A retrospective study was …

In developed countries, hematological malignancies (HM) account for 8 to 10% of cancers
diagnosed annually and one-third of patients with HM (HMP) are expected to die from their …

Background People with cancer with febrile neutropenia are at risk of severe infections and
mortality and are thus treated empirically with broad‐spectrum antibiotic therapy. However …